Month: April 2012

VALENCIA, 13 ( EUROPA PRESS) The Minister of Justice and Social Welfare, Jorge Cabré, signed Tuesday with the rector of the University of Valencia, Esteban Morcillo, the Convention of keeping the Centre Universitari de diagnosis i Atenció Primerenca-CUDAT, by which the Generalitat Valenciana intended 349.991 euros this year to this Center responsible for health care and preventive treatment of children under the age of 3 years with problems of development or risk of suffering. This Centre, that was born in 2006 as a result of the collaboration between the Ministry of Justice and Social Welfare and the Universitat de València, currently serves more than one hundred children. Of the total of seats, the Generalitat has concerted 70. The director of the Centre, Francisco Alcantud, explained that this Center treats children with all kinds of pathologies. A first group with children with diseases of good evolution, as children with low birthweight, while the second group, most abundant, consists it of children with autism, and they are up to 4 years, when they arise to education. The Center addresses the needs of children who have disorders in their development or are at risk of suffering them from a holistic point of view, whereas bio-psycho-social aspects to leverage the ability of development and well-being, enabling their integration into the family environment, school and social, as well as their personal autonomy in outpatient,....

Washington, 2 APR ( EFE).- eat soy may be a risk factor for some women who suffer from breast cancer can cause resistance to medications, according to a study presented today at the annual meeting of the American Association for cancer research (AACR). The benefits of soy, a traditional vegetable in the East which has begun to be used as an additive in foods in the West, have been widely investigated, but this study, conducted by Robert Clarke and Leena Hilakivi-Clarke professors of Medical Center Oncology Georgetown Lombardi, analyzes a new perspective. In particular, studied the reaction in laboratory rats between soy consumption and its response to tamoxifen, a drug that is usually applied after a primary breast cancer treatment to keep cancer “at Bay”. The study, which divided rats into several groups, showed that those that had fed during his lifetime with soy or some component to include soy responded well to tamoxifen. However, that began to consume soy in adult and after developing breast cancer, had a resistance to treatment response. “these results suggest that Western women who initiated adult soy consumption must quit if they are diagnosed breast cancer,” said Dr. Leena Hilakivi-Clarke said in a statement. Tamoxifen, which has been used for more than 20 years in the treatment of patients with breast cancer, is a drug in pill form that interferes with the activity...